Jan 10, 2019
Study involved four major activities to estimate current particle therapy market size. Exhaustive secondary research was done to collect information on market & its different subsegments. Report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth.

Pune, India - January 10, 2019 /MarketersMedia/ —
The particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at 9.3% CAGR. Growth of this market is largely driven by factors like various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, & increasing number of particle therapy centers worldwide.
Click Here for Sample Papers of Particle Therapy Market spread across 138 Pages, Profiling 10 Companies and Supported with 80 Tables and 36 Figures is now available at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1794631 .
Asia Pacific is one of major revenue generating regions in particle therapy market. China and Japan are major countries responsible for high growth of this regional market owing to factors like increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries.
Particle therapy market uses rays of charged positive ions, neutrons, or protons for cancer treatment. Particle therapy is a revolutionary domain of external beam radiotherapy, which combines research in physics and its application in the field of oncology. It has the potential to cure some short and long-term complications. The non-invasive characteristic of particle therapy is a major advantage that can result in more patients receiving the treatment.
Executive Summary
Premium Insights
4.1 Particle Therapy: Market Overview
4.2 Regional Analysis: Particle Therapy Market, By Product & Service
4.3 Particle Therapy Market Size, By Type
4.4 Particle Therapy Market Size, By Cancer Type
4.5 Regional Analysis: Particle Therapy Market, By Application
4.6 Particle Therapy Market, By Region
Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Advantages Offered By Particle Therapy Over Photon Therapy
5.2.1.2 Growing Global Prevalence of Cancer
5.2.1.3 Growing Adoption of Particle Therapy in Clinical Trials
5.2.1.4 Increasing Number of Particle Therapy Centers Worldwide
5.2.2 Restraints
5.2.2.1 Infrastructural Challenges in Healthcare Facilities
5.2.2.2 Affordability and Accessibility of Treatments
5.2.2.3 Unfavorable Reimbursement Policies and Limited Insurance Coverage for Particle Therapy
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.4 Industry Trends
5.2.4.1 Growing Adoption of Pencil-Beam Scanning
Get More Information on Particle Therapy Market with Top Trends, Company Profiles, Forecast and Analysis at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=1794631 .
The particle therapy market has been segmented into treatment and research applications. The research applications segment is estimated to grow at the highest rate during the forecast period due to factors such as the growing awareness about the research applications of particle therapy systems, development of cost-effective and technologically advanced diagnostic and therapeutic particle therapy systems, and the increasing industry-academia collaborations in the field of research.
Particle therapy research has following details, In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold standard & silver standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
The major players in Particle Therapy market include Ion Beam Applications SA (Belgium), Varian Medical Systems, Inc. (US), Hitachi, Ltd. (Japan), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), ProTom International, Inc. (US), Advanced Onco therapy Plc. (UK), and Danfysik A/S (Denmark).
You Can Place the Order on “Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast), Application (Treatment, Research) - Forecast to 2023” report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=1794631 .
Report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in market and provides details of competitive landscape for market leaders. Furthermore, report analyzes micro markets with respect to their individual growth trends and forecasts revenue of market segments with respect to four main regions (and the respective countries in these regions).
Breakdown of supply-side primary interviews:
• By Company Type: Tier 1–25%, Tier 2–30%, and Tier 3–45%
• By Designation:C-level–26%, Director-level–30%, and Others–44%
• By Region: North America–35%, Europe–26%, APAC–23%, and RoW–16%
Global Particle therapy market includes North America, Latin America, Europe, the Middle East, and Africa, and the Asia Pacific. The Asia Pacific region is likely to lead this global market in the future, owing to the growing healthcare expenditure, a rising number of initiatives for the promotion of latest particle therapy usage, and increasing incidences of cancer.
Contact Info:
Name: Snehal Shete
Organization: RnRMarketResearch
Address: Tower B5, Office 101, Magarpatta City SEZ, Pune-411013, India
Phone: +1 888 391 5441
Website: http://www.rnrmarketresearch.com/particle-therapy-market-by-type-heavy-ion-proton-therapy-products-cyclotron-synchrotron-synchrocyclotron-services-system-single-room-multi-room-cancer-type-pediatric-prostate-breast-application-t-st-to-2023-market-report.html
Source: MarketersMedia
Release ID: 468696
Rocker John Mellencamp reveals he suffers from ringing in his ears and pulsatile tinnitus.
A coffee shop confrontation has escalated to a foodie fight between an influencer and members of the public.
A WWE legend will need ‘more surgery’ in order to recover from his most recent medical issues.
An A-list actress and superstar musician have withdrawn their title of Hollywood power couple.
Margaret Qualley and Jack Antonoff initiated divorce proceedings on Friday (30.10.26), according to reports.
Teddi Mellencamp has revealed that she and her boyfriend, PJ Conley, have split after months of dating.
American actor Margaret Qualley and Grammy-winning songwriter and producer Jack Antonoff are calling it quits three years of their marriage in 2023.
Party Rock Anthem singer Lauren Bennett died on May 29 at the age of 36.
Black Doves, Unskilled Adults, The Assassin and North Of North, here’s what we’re watching on TV this week.
Being exposed to scary movies was once a rite of passage for all kids, such as watching Nightmare on Elm Street on VHS at a mate’s place during a sleepover. Let’s bring the traditional back.
Back To The Future legend Lea Thompson was behind the camera as a director for two episodes of Star Trek: Picard.
Jennifer Lopez has explained the inspiration behind her new song, Proof of Love.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.